The federal contract IDV award, with an ID of 75N93024D00022, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services (HHS). This single-award Indefinite Delivery Contract, potentially valued up to $146,300,000, is for pre-clinical models of infectious diseases under task areas A, B, and C. The prime contractor, Texas Biomedical Research Institute, will provide a range of services including developing...
The federal contract IDV award is for an Indefinite Delivery Contract with a ceiling value of $146,300,000 awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services. The contract is focused on providing pre-clinical models of infectious diseases to support research, development, and evaluation of medical countermeasures such as therapeutics, vaccines, and diagnostics. The contract has a single award to...
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency of the U.S. Department of Health and Human Services, awarded a $146.3 million Indefinite Delivery Contract (IDC) to Institute For Clinical Pharmacodynamics, Inc., a for-profit organization, to provide pre-clinical models of infectious diseases under Task Area C. The period of performance is from July 15, 2024 to July 14, 2031. The contract is a follow-on to a previous Preclinical Models of Infectious Diseases...
This indefinite delivery contract (IDC) was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to The Charles Stark Draper Laboratory, Inc. (Draper) for the development and employment of animal and animal replacement models of infectious diseases. The $146.3 million single-award IDC has a 7-year ordering period and supports the full range of preclinical evaluations, including screening, product evaluation, and eventual clinical evaluation of...
This indefinite delivery contract (IDC) was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to the American Foundation For Biological Research, doing business as the Biomedical Research Institute. The $146.3 million single-award IDC has a period of performance from July 15, 2024 to July 14, 2031. The purpose of this IDC is to provide NIAID with the capability and capacity to develop and employ...
The federal contract IDV is an Indefinite Delivery Contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to The University of Texas Health Science Center at San Antonio (UTHSCSA) to provide pre-clinical models of infectious diseases for up to $146.3 million over a period of 7 years. The contract supports NIAID's mission to understand, treat, and prevent infectious diseases by developing and refining small animal, non-human primate, and...
This indefinite delivery contract with the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, aims to provide preclinical models of infectious diseases to support the development and evaluation of medical countermeasures. The single award contract, valued at up to $146.3 million, has a 7-year ordering period and covers three task areas: Task Area A - Small Animal Models of Infectious Diseases Task Area B - Non-Human Primate Models of Infectious Diseases Task Area C...
This single-award Indefinite Delivery Contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services, to Battelle Memorial Institute, a non-profit organization and manufacturer of goods, to provide pre-clinical models of infectious diseases. The $146.3 million, 7-year contract has a completion date of July 14, 2031 and was awarded on July 15, 2024. The contract aims to develop and employ animal and...
This indefinite delivery contract, awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency of the U.S. federal government, aims to provide the capability and capacity to develop and employ animal and animal replacement models of infectious diseases for screening, product evaluation, and eventual clinical evaluation. The single-award contract, with a 7-year ordering period and a ceiling value of $146.3 million, was awarded to Sigmovir Biosystems, Inc., a...
This indefinite delivery contract (IDC) was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to the IIT Research Institute (IITRI), a subsidiary of the Illinois Institute of Technology. The contract has a ceiling value of $146.3 million and a period of performance through July 2031. The purpose of this IDC is to provide NIAID with a range of preclinical research services related to the development and...
The federal contract IDV award is a single-award Indefinite Delivery Contract issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Pharmacology Discovery Services Taiwan, LTD., a for-profit Taiwanese organization. The contract, valued up to $146.3M, supports NIAID's preclinical infectious disease research by providing a range of animal and animal replacement models for screening and evaluating candidate countermeasures such as therapeutics, vaccines, and diagnostics. Through task orders issued under the contract, Pharmacology Discovery Services Taiwan has supplied murine and other animal models of human infectious diseases, including bacterial infections, urinary tract infections, and diseases caused by priority pathogens. The contract aims to bridge in vitro testing and eventual clinical evaluation by developing and refining preclinical models that can assess the safety, efficacy, pharmacokinetics, and pharmacodynamics of medical countermeasures. The period of performance runs through July 2031, with the most recent task order award valued at $1.7M.